INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,000 | -86.7% | 994 | -91.1% | 0.00% | – |
Q3 2017 | $15,000 | -63.4% | 11,161 | -57.7% | 0.00% | – |
Q2 2017 | $41,000 | -51.8% | 26,396 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $85,000 | +150.0% | 26,396 | +5.9% | 0.00% | – |
Q4 2016 | $34,000 | +88.9% | 24,920 | +115.0% | 0.00% | – |
Q3 2016 | $18,000 | -69.5% | 11,591 | +3.5% | 0.00% | -100.0% |
Q1 2016 | $59,000 | -57.2% | 11,194 | -11.4% | 0.00% | 0.0% |
Q2 2015 | $138,000 | – | 12,635 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |